| Date Filed | Type | Description |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| WILSON KAREN J (Director) has filed a Form 4 on Angion Biomedica Corp.|
Txns:
| Granted 15,000 options to buy
@ $15.01, valued at
$225.2k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/27/2020 |
4
| WILSON KAREN J (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 65,700 options to buy
@ $6.95, valued at
$456.6k
|
|
| 08/27/2020 |
3
| WILSON KAREN J (Director) has filed a Form 3 on Vaxart, Inc. |
| 03/07/2019 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 276 shares
@ $135.82, valued at
$37.5k
Paid exercise price by delivering 302 shares
@ $135.82, valued at
$41k
|
|
| 03/04/2019 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,500 shares
@ $0
Granted 576 options to buy
@ $140.03, valued at
$80.7k
Granted 8,174 options to buy
@ $140.03, valued at
$1.1M
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2018 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 3,899 shares
@ $155, valued at
$604.3k
|
|
| 03/07/2018 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 302 shares
@ $143.39, valued at
$43.3k
|
|
| 03/05/2018 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,200 shares
@ $0
Granted 681 options to buy
@ $140.67, valued at
$95.8k
Granted 7,319 options to buy
@ $140.67, valued at
$1M
|
|
| 02/28/2018 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 537 shares
@ $147.44, valued at
$79.2k
Paid exercise price by delivering 324 shares
@ $143.8, valued at
$46.6k
|
|
| 04/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2017 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 4,750 shares
@ $152.24, valued at
$723.1k
Sold 6,708 shares
@ $152.24, valued at
$1M
Exercised 6,708 options to buy
@ $46.83, valued at
$314.1k
Exercised 4,750 options to buy
@ $59.13, valued at
$280.9k
|
|
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/11/2016 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,467 shares
@ $150.01, valued at
$220.1k
|
|
| 04/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/15/2016 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 5,007 shares
@ $150, valued at
$751.1k
|
|
| 04/08/2016 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 2,161 shares
@ $140.9, valued at
$304.5k
|
|
| 03/09/2016 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 563 shares
@ $127.84, valued at
$72k
|
|
| 09/04/2013 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 2,000 shares
@ $87.62, valued at
$175.2k
|
|
| 08/13/2013 |
4
| WILSON KAREN J (SVP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,409 shares
@ $80.88, valued at
$114k
|
|
| 03/06/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2012 |
4
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $46.83, valued at
$1.4M
|
|
| 03/13/2012 |
4
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 8,000 shares
@ $49.56, valued at
$396.5k
|
|
| 01/18/2012 |
4
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 10,292 shares
@ $0
Granted 13,007 options to buy
@ $27.46, valued at
$357.2k
|
|
| 01/18/2012 |
3
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 3 on Jazz Pharmaceuticals plc |
| 01/18/2012 |
4
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 10,292 shares
@ $0
Disposed/sold 13,007 options to buy
@ $27.46, valued at
$357.2k
|
|
| 01/13/2012 |
4
| WILSON KAREN J (VP, Finance & PAO) has filed a Form 4 on JAZZ PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 26,907 shares
@ $48.6, valued at
$1.3M
Exercised 36,993 options to buy
@ $27.46, valued at
$1M
|
|
|